Literature DB >> 11010940

Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients.

M M van Bakel1, G Printzen, B Wermuth, U N Wiesmann.   

Abstract

BACKGROUND: Subjects consuming protein-restricted diets, such as patients with phenylketonuria (PKU) or milder hyperphenylalaninemias (HPAs) are at risk of selenium deficiency. Selenium is a cofactor of the antioxidant enzyme glutathione peroxidase and of the thyroid hormone converting enzyme thyroxine deiodinase.
OBJECTIVE: Our goal was to investigate the effects of low plasma selenium on antioxidant and thyroid hormone status.
DESIGN: We assessed plasma selenium, plasma total antioxidant status and the individual components thereof, erythrocyte antioxidant status, and plasma thyroid hormones in 24 PKU and 10 HPA patients and in 42 age-matched control subjects.
RESULTS: Selenium was significantly lower in both PKU and HPA patients than in control subjects and the PKU patients had lower values than did the HPA patients. Total antioxidant status was lower in both patient groups than in the control group, whereas alpha-tocopherol, albumin, and uric acid were not significantly different among groups. Plasma selenium correlated well (r = 0.76) with erythrocyte glutathione peroxidase. PKU patients had lower glutathione peroxidase activity than did HPA patients and control subjects and lower glutathione concentrations than did control subjects. Both patient groups had lower superoxide dismutase activity than did control subjects. Free triiodothyronine was higher in both patient groups than in control subjects, whereas free thyroxine was higher in the PKU patients only. Free thyroxine and reverse triiodothyronine were inversely correlated with selenium.
CONCLUSION: Supplementation with selenium seems to be advisable for patients consuming diets low in natural protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010940     DOI: 10.1093/ajcn/72.4.976

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  19 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Nutritional Management of Phenylketonuria.

Authors:  Erin L Macleod; Denise M Ney
Journal:  Ann Nestle Eng       Date:  2010-06

Review 3.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

4.  Investigation of oxidative stress parameters in treated phenylketonuric patients.

Authors:  A Sitta; A G Barschak; M Deon; T Terroso; R Pires; R Giugliani; C S Dutra-Filho; M Wajner; C R Vargas
Journal:  Metab Brain Dis       Date:  2006-12-05       Impact factor: 3.584

5.  Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.

Authors:  Tarsila Barros Moraes; Carlos Eduardo Diaz Jacques; Andrea Pereira Rosa; Giovana Reche Dalazen; Melaine Terra; Juliana Gonzalez Coelho; Carlos Severo Dutra-Filho
Journal:  Cell Mol Neurobiol       Date:  2012-12-12       Impact factor: 5.046

6.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

7.  Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.

Authors:  A Sitta; C S Vanzin; G B Biancini; V Manfredini; A B de Oliveira; C A Y Wayhs; G O S Ribas; L Giugliani; I V D Schwartz; D Bohrer; S C Garcia; M Wajner; C R Vargas
Journal:  Cell Mol Neurobiol       Date:  2010-12-30       Impact factor: 5.046

Review 8.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

9.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

10.  The impact of cardiopulmonary bypass on selenium status, thyroid function, and oxidative defense in children.

Authors:  R Holzer; B Bockenkamp; P Booker; P Newland; G Ciotti; M Pozzi
Journal:  Pediatr Cardiol       Date:  2004-05-12       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.